文献速递冠心病

真实世界中 iFR 与 FFR 指导冠状动脉生理评估的长期结局比较

Long‐Term Outcomes of iFR‐ Versus FFR‐Guided Coronary Physiology in Real‐World Clinical Practice
RSS 订阅 · Catheterization and Cardiovascular Interventions · 2026-10-05

这项单中心回顾性研究纳入 2012–2022 年连续接受有创冠脉生理学评估的 1104 例患者,其中 FFR 组 428 例、iFR 组 676 例。结果显示 iFR 指导管理与更高的长期全因死亡和 MACE 相关,而心肌梗死和非计划血运重建发生率相似。

要点

  • iFR 组功能学显著狭窄检出率低于 FFR 组(42% vs 49%,p=0.001)
  • iFR 指导管理长期全因死亡风险显著高于 FFR(HR 1.52,95% CI 1.19–1.93)
  • iFR 组 MACE 风险也显著升高(HR 1.47,95% CI 1.19–1.82),主要由死亡驱动

核心结论

  • 在真实世界队列中,iFR 指导的冠脉生理评估与 FFR 指导相比,长期全因死亡和 MACE 更高
  • 两组心肌梗死和非计划血运重建发生率相似

研究设计与样本

  • 回顾性单中心研究,纳入 2012–2022 年连续接受有创生理学评估的患者共 1104 例
  • FFR 组 428 例,iFR 组 676 例,基线临床特征组间均衡
  • 采用 Kaplan–Meier 估计和 Cox 比例风险模型进行时间-事件分析

主要发现

  • iFR 组功能学显著狭窄检出率低于 FFR 组(42% vs 49%,p=0.001)
  • iFR 组血运重建延迟率更高
  • iFR 指导管理全因死亡风险显著高于 FFR 指导(HR 1.52,95% CI 1.19–1.93;p<0.001)
  • iFR 组 MACE 风险显著升高(HR 1.47,95% CI 1.19–1.82;p<0.001),主要由死亡驱动
  • 两组心肌梗死和非计划血运重建无差异

关键数值与推荐

  • 功能学显著狭窄:iFR 组 42%,FFR 组 49%,p=0.001
  • 全因死亡:HR 1.52,95% CI 1.19–1.93,p<0.001
  • MACE:HR 1.47,95% CI 1.19–1.82,p<0.001

临床怎么用

  • 对于需要长期预后评估的冠脉生理学指导决策,应关注 iFR 与 FFR 之间可能存在的死亡率差异
  • iFR 指导可能更多延迟血运重建,需结合患者整体风险评估长期管理策略

局限性

  • 回顾性单中心观察性设计,存在残余混杂可能
  • 原文未提供组间基线及随访时间等更多细节

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Background Fractional flow reserve (FFR) is the reference standard for invasive physiological assessment of intermediate coronary stenoses. Instantaneous wave-free ratio (iFR) was introduced as a non-hyperemic alternative, and the DEFINE-FLAIR and iFR-SWEDEHEART trials demonstrated noninferiority of iFR- versus FFR-guided management at 1 year, leading to widespread adoption of iFR. However, long-term follow-up and pooled analyses subsequently suggested higher all-cause mortality with iFR-guided assessment. We therefore compared long-term outcomes of iFR- versus FFR-guided coronary physiology assessment in real-world clinical practice. Methods This retrospective single-center study included consecutive patients undergoing invasive physiological assessment between 2012 and 2022. Patients were managed according to FFR- or iFR-guided strategies, with revascularization performed for physiologically significant lesions and deferred otherwise. The primary endpoint was all-cause mortality. Secondary endpoints included major adverse cardiovascular events (death from any cause, myocardial infarction or unplanned revascularization), and the individual componentes of the secondary composite endpoint. Time-to-event analyses were performed using Kaplan–Meier estimates and Cox proportional hazards models. Results A total of 1104 patients were included, comprising 428 patients in the FFR group and 676 in the iFR group. Baseline clinical characteristics were well balanced between groups. Functionally significant stenoses were less frequently identified in the iFR group (42% vs. 49%, p = 0.001), resulting in higher rates of revascularization deferral. During long-term follow-up, iFR-guided management was associated with significantly higher all-cause mortality compared with FFR-guided management (HR 1.52, 95% CI 1.19–1.93; p < 0.001). The incidence of MACE was also significantly higher with iFR (HR 1.47, 95% CI 1.19–1.82; p < 0.001), driven by mortality, with no differences in myocardial infarction or unplanned revascularization. Conclusions In this large real-world cohort, iFR-guided coronary physiological assessment was associated with higher long-term all-cause mortality and MACE compared with FFR-guided management, while rates of myocardial infarction and unplanned revascularization were similar. These findings parallel long-term observations from randomized clinical trials and support the need for further studies evaluating the prognostic implications of resti

来源:Catheterization and Cardiovascular Interventions,查看原文。版权归原作者所有。

引用

  1. Catheterization and Cardiovascular Interventions:Long‐Term Outcomes of iFR‐ Versus FFR‐Guided Coronary Physiology in Real‐World Clinical Practice

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。